Fortimel Taste Optimization in Oncology Patients for Nutritional Support

This study aims to explore the use and effectiveness of a nutritional drink called Fortimel, specifically designed for cancer patients. These patients often require special nutritional support to maintain their health during treatment. The study focuses on how well patients tolerate different flavors of this drink and whether it improves their overall nutrition and quality of life. By observing how patients react to this drink in a real-world setting, the study seeks to enhance the nutritional care for oncology patients, potentially leading to better compliance with dietary recommendations and improved health outcomes. Participants in this study will receive a ready-to-drink formula, provided in four different flavors over a 28-day period, with one or two bottles consumed daily. Throughout the study, the nutritional status and quality of life of the patients are assessed at various points before and after they start drinking the formula. To help participants stick to the regimen, a support platform offers guidance on nutrition and diet. The study involves a follow-up period lasting up to 60 days after the intervention, ensuring that the effects of the nutritional support are carefully monitored and documented.